<code id='F38B040186'></code><style id='F38B040186'></style>
    • <acronym id='F38B040186'></acronym>
      <center id='F38B040186'><center id='F38B040186'><tfoot id='F38B040186'></tfoot></center><abbr id='F38B040186'><dir id='F38B040186'><tfoot id='F38B040186'></tfoot><noframes id='F38B040186'>

    • <optgroup id='F38B040186'><strike id='F38B040186'><sup id='F38B040186'></sup></strike><code id='F38B040186'></code></optgroup>
        1. <b id='F38B040186'><label id='F38B040186'><select id='F38B040186'><dt id='F38B040186'><span id='F38B040186'></span></dt></select></label></b><u id='F38B040186'></u>
          <i id='F38B040186'><strike id='F38B040186'><tt id='F38B040186'><pre id='F38B040186'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:hotspot    Page View:258
          Adobe

          The Biden administration moved Wednesday to force insurance companies to give specific reasons for denying coverage, and to speed up the pre-approval process in general.

          The new rule applies to health insurance companies that offer Medicare, Medicaid, Children’s Health Insurance Program, and Obamacare plans. It concerns so-called prior authorization requests, and will require insurers to return urgent requests within 72 hours and non-urgent requests within seven days.

          advertisement

          The changes are a win for patients seeking care, but also for health care providers like hospitals and physicians. Executives from California-based Sutter Health, Massachusetts General Brigham, and others repeatedly cited the rise in insurer denials since the pandemic at last week’s J.P. Morgan Healthcare conference.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          FDA's naming rule on biosimilars has undermined competition
          FDA's naming rule on biosimilars has undermined competition

          AdobeIrecentlytriedtoorderwhitebloodcellgrowthfactor(pegfilgrastim)biosimilarforoneofmypatients.This

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Why Congress must ban federal programs from using QALYs

          AdobeThirty-fiveyearsago,IwasproudtointroducetheAmericanswithDisabilitiesActintheHouseofRepresentati